News
"Glossy drawings and new press releases cannot disguise the reality: this project poses serious risks and still faces a ...
On a very good Friday for the stock market, Biohaven 's (NYSE: BHVN) performance was exceptional. The clinical-stage biotech 's share price inflated by over 6% that trading session thanks to ...
Levi & Korsinsky, LLP notifies investors in Biohaven Ltd. ("Biohaven Ltd." or the "Company") (NYSE: BHVN) of a class action securities lawsuit.
Investor's Business Daily on MSN15h
Biohaven Surges After FDA Cancels Key Meeting. But Is It Good News?
Biohaven stock surged early Friday after the FDA canceled an upcoming meeting to discuss the benefits and risks of its drug, ...
Biohaven Ltd. (NYSE:BHVN) stock is trading higher on Friday following an update with respect to its New Drug Application for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback